A 57-year-old woman with chronic obstructive pulmonary disease (COPD) has received the world's first fully robotic double ...

The list for the next round of medicines that ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

A new study suggests COPD patients experience improved lung ... as both can be fearful of losing control of the disease in a change of medication. The CRYSTAL trial is the first large-scale ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Chronic obstructive pulmonary disease (COPD), the fourth leading cause of death globally, claimed 3.5 million lives in 2021, approximately 5% of all global deaths with a growing and disproportionate ...

Dupixent (dupilumab) is a prescription drug that’s used to treat certain ... Dupixent is used to treat eosinophilic COPD in adults. When prescribed for this condition, Dupixent is used in ...

Nebulizers for kids can offer a convenient way to give medication to kids and relieve respiratory illness. Explore the best ...

Seek immediate care if you are unable to breathe because of mucus in the airway. Regularly clearing mucus from your lungs is part of living with bronchiectasis, COPD, and other health conditions.

A new study from KRIMS Hospital highlights that a staggering 81% of Chronic Obstructive Pulmonary Disease (COPD) patients skip regular treatment, raising concerns about disease management. Dr. Ashok ...

ic.ac.uk National surveys have revealed significant differences in patient outcomes following admission to hospital with acute exacerbation of COPD which are likely to be due to variations in care. We ...